HIGHLIGHTS: New funds, Mind the Byte begins bankruptcy proceedings, rounds in biotech firms and advances in research

The goodbye to Josep Esteve added a bittersweet note to a month of new hires and investment news

‘Nature’ and ‘Scientific American’ prepare a report on BioRegion of Catalonia

It will be published at the end of 2019 and companies and organizations can participate with promotional content

10 projects chosen to participate in 2nd edition of CRAASH Barcelona

The acceleration program promoted by Biocat and CIMIT with EIT Health received 65 applications from 21 countries

Companies and researchers search for solutions to innovation challenges at Open Innovation Forum

The first session hosted 76 meetings between companies and research centers

HIGHLIGHTS: New investment fund and high-impact advances in HIV and cancer

Asabys kicks off with €30 million, IrsiCaixa announces 2nd case of HIV in remission in the world and Peptomyc makes advances with its oncology drug

d·HEALTH Barcelona fellows scout for unmet needs at Clínic, Vall d’Hebron and Can Ruti

The teams in this program promoted by Biocat to train entrepreneurs and innovators in healthcare do a two-month clinical immersion

More than 20 companies from the BioRegion of Catalonia to participate in BIO-Europe Spring 2019

The congress was held from 25 to 27 March in Vienna

Call open for projects and companies in the BioRegion interested in contacts with French investors

Biocat is promoting The Investment Readiness Series – France Edition with Business France and ACCIÓ Paris and support from Cuatrecasas

HIGHLIGHTS: Licenses, calls in the sector, 5G, mini-kidneys, new hires and goodbyes

Results from publicly traded companies, European grants and scientific publications round out the headlines for February in the BioRegion

Biocat seeks therapies in the early stage

A new program will put drug-discovery projects in contact with partners to set up research collaboration models